278 related articles for article (PubMed ID: 28405163)
1. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
2. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.
Xiang B; Dong DW; Shi NQ; Gao W; Yang ZZ; Cui Y; Cao DY; Qi XR
Biomaterials; 2013 Sep; 34(28):6976-91. PubMed ID: 23777916
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform.
Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X
J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914
[TBL] [Abstract][Full Text] [Related]
4. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
5. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
[TBL] [Abstract][Full Text] [Related]
6. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.
Zhao T; Liang C; Zhao Y; Xue X; Ma Z; Qi J; Shen H; Yang S; Zhang J; Jia Q; Du Q; Cao D; Xiang B; Zhang H; Qi X
J Nanobiotechnology; 2022 Apr; 20(1):177. PubMed ID: 35366888
[TBL] [Abstract][Full Text] [Related]
7. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
[TBL] [Abstract][Full Text] [Related]
8. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
[TBL] [Abstract][Full Text] [Related]
9. siRNA-loaded poly(histidine-arginine)
Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
[TBL] [Abstract][Full Text] [Related]
10. Photolabile-caged peptide-conjugated liposomes for siRNA delivery.
Xie X; Yang Y; Yang Y; Mei X
J Drug Target; 2015; 23(9):789-99. PubMed ID: 25675844
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
12. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.
Liu HM; Zhang YF; Xie YD; Cai YF; Li BY; Li W; Zeng LY; Li YL; Yu RT
Int J Nanomedicine; 2017; 12():1065-1083. PubMed ID: 28223799
[TBL] [Abstract][Full Text] [Related]
14. Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs.
Mokhtarieh AA; Kim S; Lee Y; Chung BH; Lee MK
Biochem Biophys Res Commun; 2013 Mar; 432(2):359-64. PubMed ID: 23384441
[TBL] [Abstract][Full Text] [Related]
15. pH-responsive cationic liposome for endosomal escape mediated drug delivery.
Rayamajhi S; Marchitto J; Nguyen TDT; Marasini R; Celia C; Aryal S
Colloids Surf B Biointerfaces; 2020 Apr; 188():110804. PubMed ID: 31972443
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
Wang HX; Yang XZ; Sun CY; Mao CQ; Zhu YH; Wang J
Biomaterials; 2014 Aug; 35(26):7622-34. PubMed ID: 24929619
[TBL] [Abstract][Full Text] [Related]
17. Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular Delivery of Functional siRNA to Triple Negative Breast Cancer Cells.
Biswas A; Chakraborty K; Dutta C; Mukherjee S; Gayen P; Jan S; Mallick AM; Bhattacharyya D; Sinha Roy R
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4719-4736. PubMed ID: 30628773
[TBL] [Abstract][Full Text] [Related]
18. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
19. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
[TBL] [Abstract][Full Text] [Related]
20. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
